Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Graff-Cailleaud

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 3, 2018
[Prostate brachytherapy: New techniques, new indications]P Blanchard, P Graff-Cailleaud, A Bossi
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2022
[Challenges and limits of therapeutic de-escalation for papillomavirus-related oropharyngeal cancer]A Modesto, P Graff Cailleaud, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2020
[Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited ?]M Lapeyre, J Biau, J Miroir, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2021
Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)G Peyraga, T Lizee, J Khalifa, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy for oral cavity cancersM Lapeyre, S Racadot, S Renard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 3, 2018
[Prostate brachytherapy: New techniques, new indications]P Blanchard, P Graff-Cailleaud, A Bossi
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2022
[Challenges and limits of therapeutic de-escalation for papillomavirus-related oropharyngeal cancer]A Modesto, P Graff Cailleaud, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2020
[Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited ?]M Lapeyre, J Biau, J Miroir, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2021
Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)G Peyraga, T Lizee, J Khalifa, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy for oral cavity cancersM Lapeyre, S Racadot, S Renard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Pageof 1